ANTIFUNGAL ACTIVITY OF STATINS AND THEIR INTERACTION WITH AMPHOTERICIN B AGAINST CLINICALLY IMPORTANT ZYGOMYCETES

被引：17
作者：
Galgoczy, L. [1 ]
Lukacs, Gyoengyi [1 ]
Nyilasi, Ildiko [1 ]
Papp, T. [1 ]
Vagvolgyi, Cs. [1 ]
机构：
[1] Univ Szeged, Fac Sci & Informat, Dept Microbiol, Szeged, Hungary
来源：
ACTA BIOLOGICA HUNGARICA | 2010年 / 61卷 / 03期
关键词：
Statin; amphotericin B; Zygomycetes; drug interaction; synergism; LOVASTATIN; PROTEIN; SCEDOSPORIUM; EFFICACY; FUSARIUM; SAFETY; MOLDS;
D O I：
10.1556/ABiol.61.2010.3.11
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
The in vitro antifungal activity of different statins and the combinations of the two most effective ones (fluvastatin and rosuvastatin) with amphotericin B were investigated in this study on 6 fungal isolates representing 4 clinically important genera, namely Absidia, Rhizomucor, Rhizopus and Syncephalastrum. The antifungal effects of statins revealed substantial differences. The synthetic statins proved to be more effective than the fungal metabolites. All investigated strains proved to be sensitive to fluvastatin. Fluvastatin and rosuvastatin acted synergistically and additively with amphotericin B in inhibiting the fungal growth in clinically available concentration ranges. Results suggest that statins combined with amphotericin B have a therapeutic potential against fungal infections caused by Zygomycetes species.
引用
收藏
页码：356 / 365
页数：10
相关论文
共 38 条
[1]   In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents [J].
Almyroudis, Nikolaos G. ;
Sutton, Deanna A. ;
Fothergill, Annette W. ;
Rinaldi, Michael G. ;
Kusne, Shimon .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (07) :2587-2590
[2]   Safety of statins - Focus on clinical pharmacokinetics and drug interactions [J].
Bellosta, S ;
Paoletti, R ;
Corsini, A .
CIRCULATION, 2004, 109 (23) :50-57
[3]  
Buemi Michele, 2007, Cardiovascular & Hematological Disorders - Drug Targets, V7, P7
[4]   Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole [J].
Chamilos, G ;
Lewis, RE ;
Kontoyiannis, DP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (01) :96-103
[5]   Zygomycosis: the re-emerging fungal infection [J].
Chayakulkeeree, M. ;
Ghannoum, M. A. ;
Perfect, J. R. .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2006, 25 (04) :215-229
[6]   Mechanisms of statin-mediated inhibition of small G-protein function [J].
Cordle, A ;
Koenigsknecht-Talboo, J ;
Wilkinson, B ;
Limpert, A ;
Landreth, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (40) :34202-34209
[7]   Pharmacokinetic interactions between statins and fibrates [J].
Corsini, A ;
Bellosta, S ;
Davidson, MH .
AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (9A) :44K-49K
[8]   New insights into the pharmacodynamic and pharmacokinetic properties of statins [J].
Corsini, A ;
Bellosta, S ;
Baetta, R ;
Fumagalli, R ;
Paoletti, R ;
Bernini, F .
PHARMACOLOGY & THERAPEUTICS, 1999, 84 (03) :413-428
[9]  
Eliopolous GM., 1996, Antibiotics in laboratory medicine, P330
[10]   Interactions between statins and Penicillium chrysogenum antifungal protein (PAF) to inhibit the germination of sporangiospores of different sensitive Zygomycetes [J].
Galgoczy, Laszlo ;
Papp, Tamas ;
Lukacs, Gyongyi ;
Leiter, Eva ;
Pocsi, Istvan ;
Vagvolgyi, Csaba .
FEMS MICROBIOLOGY LETTERS, 2007, 270 (01) :109-115
1234